Drug Discovery News
-
Australia approves drug that can 'melt away' cancer cells
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2017
Singapore: Australian authorities have just approved a new drugvenetoclax that is touted to have the power to "melt away...Read more
-
Boehringer Ingelheim bevacizumab biosimilar candidate demonstrates bioequivalence to Avastin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Nov, 2016
Boehringer Ingelheim announced new data from the Phase I INVICTAN-1 study, which show that BI 695502, its bevacizumab bi...Read more
-
NUS scientists discover the switch that makes breast cancer cells aggressive
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2016
Singapore: A team of scientists from National University of Singapore (NUS) has established novel insights into the rel...Read more
-
"Prevalence of COPD in Asia is similar to western countries"
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 27 Oct, 2016
GlaxoSmithKline and biopharmaceutical company, Innoviva, have concluded Salford Lung Study (SLS), a Phase IIIb multi-cen...Read more
-
Singapore develops oral-anti-diabetic drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Oct, 2016
Singapore: Singapore has completed phase I clinical trial of an oral-anti-diabetic drug developed by Department of Pharm...Read more
-
South Korea's Hanmi pharmaceuticals in troubled waters!
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Oct, 2016
Singapore: New blockbuster cancer drug from South Korea's Hanmi pharmaceuticals is in troubled waters after a patient di...Read more
-
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 04 Oct, 2016
Singapore: Waters Corporation recently collaborated with Bioprocessing Technology Institute (BTI), a research institute ...Read more
-
Renowned neurologist, Allen Roses, passes away
Drug Discovery | Influencers | By BioSpectrum Bureau | 2 Comment | 05 Oct, 2016
Singapore: Allen David Roses, a renowned neurologist who pioneered breakthrough research in Alzhiemer's Disease, passed ...Read more
-
Australia changes drug approval norms to speed up approval process
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2016
Singapore: With a view to speed up the approval process and improve access to breakthrough drugs, the Australian federal...Read more
-
Semaglutide reduces risk of cardiovascular problems among type 2 Diabetic patients
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Sep, 2016
Munich: Danish Drug maker Novo Nordisk recently announced that patients treated with Semaglutide, an investigational glu...Read more
-
Eisai receives license for new indication for anticancer agent Kisplyx
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2016
TOKYO: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received license from the...Read more
-
Singapore develops new protein to alter DNA in living cells
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2016
Singapore: Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher pre...Read more
-
Glenmark receives ANDA approval for Nystatin, Triamcinolone Acetonide ointment
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2016
Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food & Drug Administrat...Read more
-
Novogen progresses on drugs against genetic, degenerative disorders
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Nov, 2013
Singapore: Australian company Novogen, engaged in a pilot program aimed at breakthrough development of drugs to treat a ...Read more
-
Glenmark develops first-of-its-kind antibody
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2013
Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical...Read more
-
Tivozanib shows superiority over sorafenib in trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
Singapore: Investigational agent, tivozanib, has demonstrated statistically significant and clinically meaningful PFS su...Read more
-
Pluristem secures Japan's PMDA nod on regenerative drug trial protocol
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015
Pluristem Therapeutics Inc., Israel's developer of placenta-based cell therapy products, has reached an agreement with J...Read more
-
Bone Medical reveals results of arthritis study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Singapore: Australia-based Bone Medical, a biopharmaceutical company focused on the development of new medicines for mus...Read more
